Xiong Cai,Haixiao Zhai,Chengjung Lai,Changgeng Qian,Rudi Bao
申请号：
US13435062
公开号：
US08710219B2
申请日:
2012.03.30
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The invention provides a compound of Formula I,Pharmaceutical compositions comprising such compounds and the use of such compounds in the treatment of phosphoinositide 3-kinase related diseases and disorders such as cancer. The instant application further relates to the treatment of histone deacetylase related disorders and diseases related to both histone deacetylase and phosphoinositide 3-kinase.
